Skip to main content

User account menu

  • Safety Data
  • Package Inserts

Main navigation

  • Women's Health Products
    • Breast Health
    • Gynecological Health
    • Sexual Health
    • Body Composition
    • Skeletal Health
  • Lab Technologies
    • Tests
    • Cytology
    • Molecular Diagnostics
    • Collection Devices
    • Screening Technologies
  • About
    • Hologic Highlights
    • Coronavirus Update
    • Investor Relations
    • Media Library
    • Events
    • Sustainability
    • Global Access Initiative
    • Philanthropy
    • Project Health Equality
    • Hologic Timeline
    • Real Women's Stories
    • Well Woman
    • Locations
  • Support
    • Safety Data Sheets
    • Package Inserts
    • Contact
    • Medical Education
    • Order Online (iStore)
    • Contact our Compliance Hotline
  • Careers
  • Women's Health Index

Second top menu

  • Women's Health Index
  • Investors
  • Careers
  • Contact us
  • Sign in

Site selector

  • Country: USA
    • Canada
    • China
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands

Site selector

  • Country: USA
    • Canada
    • China
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands

User account menu

  • Safety Data
  • Package Inserts

Second top menu

  • Women's Health Index
  • Investors
  • Careers
  • Contact us
  • Sign in
Home

Main navigation (Header)

  • Women's Health Products
    • Breast Health
    • Gynecological Health
    • Sexual Health
    • Body Composition
    • Skeletal Health
  • Lab Technologies
    • Tests
    • Cytology
    • Molecular Diagnostics
    • Collection Devices
    • Screening Technologies
  • About
    • Hologic Highlights
    • Coronavirus Update
    • Investor Relations
    • Media Library
    • Events
    • Sustainability
    • Global Access Initiative
    • Philanthropy
    • Project Health Equality
    • Hologic Timeline
    • Real Women's Stories
    • Well Woman
    • Locations
  • Support
    • Safety Data Sheets
    • Package Inserts
    • Contact
    • Medical Education
    • Order Online (iStore)
    • Contact our Compliance Hotline
  • Careers
  • Women's Health Index
Home
Back to Products

Aptima® Trichomonas Vaginalis Assay

Find Support
Placeholder image
    Overview

    The Most Common Curable STI

    Trichomonas vaginalis (TV) is the most common curable STI in the United states.1 Over 3.7 million people in the United States have TV, which is a higher prevalence than chlamydia and gonorrhea infections combined.1 The CDC recommends testing women for TV infection if they are symptomatic or at increased risk of infection.2 The CDC and ACOG also recommend the use of a highly sensitive and specific test, such as the Aptima® Trichomonas vaginalis assay.2,3

    Detect Up To 100% of TV Infections

    The Aptima Trichomonas vaginalis assay is an rRNA-based NAAT that provides up to 100% sensitivity in detecting TV for both symptomatic and asymptomatic patients.4 This assay overcomes challenges associated with traditional, less sensitive methodologies because it can detect a fraction of one organism, whereas wet mount requires at least 10,000 motile organisms/mL to visualize.4,5

    Ordering Information

    Learn More

    Safety Data Sheets

    Learn More

    Find Support

    All Other Requests

    References:
    1. CDC. CDC Fact Sheet: Incidence, Prevalence and Cost of Sexually Transmitted Infections in the United States. https://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf. February 2013.  2. Workowski, et al. Sexually Transmitted Infections Treatment Guidelines 2021. MMWR Recomm Rep 2021;70(4):1-187.doi.org/10.15585/mmwr.rr7004a1. 3. ACOG Practice Bulletin. Vaginitis in Nonpregnant Patients. Washington; DC: American College of Obstetricians and Gynecologists; 2020:135:e1-17. No. 215. 4. Aptima Trichomonas vaginalis Assay. US package insert 503684. Hologic, Inc., 2020. 5. Garber GE. The laboratory diagnosis of Trichomonas vaginalis. Can J Infect Dis Med Microbiol. 2005; 16(1):35-38. doi.org/10.1155/2005/373920
    Package Inserts

    Related Products

    Aptima® STIs

    Aptima® STIs

    Aptima®Mycoplasma genitalium assay

    Aptima®Mycoplasma genitalium assay

    Aptima® Herpes Simplex 1&2 assay

    Aptima® Herpes Simplex 1&2 assay

    Aptima Combo 2® assay (for CT/NG)

    Aptima Combo 2® assay (for CT/NG)

    Aptima® Multitest Swab Specimen Collection Kit

    Aptima® Multitest Swab Specimen Collection Kit

    Panther® Scalable Solutions

    Panther® Scalable Solutions

    Back to Products

    Aptima® Trichomonas vaginalis assay

    Find Support
    Placeholder image
      Overview

      Identify a Common Viral Threat

      Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3

      The Accurate Testing Needed For Proper Treatment

      NAATs, such as the Aptima® HSV 1 & 2 assay, are recommended by the CDC and WHO for HSV diagnosis. They are increasingly preferred over viral culture to diagnose genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.2,3 The Aptima HSV 1 & 2 assay distinguishes between HSV-1 and HSV-2 with significant reduction in hands-on time for laboratory professionals when compared to culture and other instrument platforms.4-6

      Safety Data Sheets

      Learn More

      Need Support?

      All Other Requests

      References
      1. WHO. Herpes simplex virus. World Health Organization. Last reviewed May 1, 2020. Accessed. September 10, 2021. https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus. 2. WHO. WHO guidelines For The Treatment of Genital Herpes Simplex Virus. World Health Organization. Last reviewed March 11, 2016. Accessed September 10, 2021. https://www.who.int/publications/i/item/978924154987 3. Workowski, et al. Sexually Transmitted Infections Treatment Guidelines 2021. MMWR Recomm Rep 2021;70.  4. Aptima HSV 1 & 2 assay. US package insert AW-15346-001. Hologic, Inc., 2019. 5. LeGoff J, et al. Diagnosis of genital herpes simplex virus infection in the clinical laboratory. Virol J. 2014;11:83. doi:10.1186/1743-422X-11-83. 6. A. Jassem, Comparative Evaluation of the Aptima HSV 1&2 Assay and a Lab Developed Real-time PCR Test for Detection of HSV-1 and HSV-2 Viruses, presented at ESCV 2016 Poster No. PP20. 
      Package Inserts

      Related Products

      Aptima® STIs

      Aptima® STIs

      Aptima® Mycoplasma Genitalium Assay

      Aptima® Mycoplasma Genitalium Assay

      Aptima Combo 2® assay (for CT/NG)

      Aptima Combo 2® assay (for CT/NG)

      Aptima® Herpes Simplex 1& 2 assay

      Aptima® Herpes Simplex 1& 2 assay

      Aptima® Multitest Swab Specimen Collection Kit

      Aptima® Multitest Swab Specimen Collection Kit

      Panther® Scalable Solutions

      Panther® Scalable Solutions

      Main navigation (Footer)

      • Women's Health Products
        • Breast Health
        • Gynecological Health
        • Sexual Health
        • Body Composition
        • Skeletal Health
      • Lab Technologies
        • Tests
        • Cytology
        • Molecular Diagnostics
        • Collection Devices
        • Screening Technologies
      • About
        • Hologic Highlights
        • Coronavirus Update
        • Investor Relations
        • Media Library
        • Events
        • Sustainability
        • Global Access Initiative
        • Philanthropy
        • Project Health Equality
        • Hologic Timeline
        • Real Women's Stories
        • Well Woman
        • Locations
      • Support
        • Safety Data Sheets
        • Package Inserts
        • Contact
        • Medical Education
        • Order Online (iStore)
        • Contact our Compliance Hotline
      • Careers
      • Women's Health Index
      Hologic footer logo

      © Copyright 2022 Hologic, Inc. All rights reserved.

      Health logo

      Footer menu

      • Privacy Policy
      • Terms & Conditions
      • Patent Info
      • AdvaMed Code of Ethics
      • International Modern Slavery Statement

      Footer social links

      • Twitter
      • Linkedin
      • Facebook
      • Glassdoor
      • Youtube
      • Instagram